prednisolone has been researched along with Infections, Coronavirus in 17 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| " With only few case studies published on SARS-CoV-2 infection in patients with rheumatic diseases, we report a 25-year-old male who developed moderate coronavirus disease 2019 (COVID-19) with fever, mild dyspnea, and no major complications despite having received high-dose prednisolone, cyclophosphamide, and rituximab for the treatment of highly active, life-threatening eosinophilic granulomatosis with polyangiitis (EGPA)." | 3.96 | COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis. ( Craig-Mueller, N; Hengel, H; Huzly, D; Kern, WV; Panning, M; Schramm, MA; Thiel, J; Venhoff, N; Voll, RE; Wagner, D, 2020) |
| " A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted with chief complaints of fever, chills, malaise, myalgia, and dyspnea." | 3.96 | COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? ( Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V, 2020) |
| "A 61-year old patient with ankylosing spondylitis who was on secukinumab therapy for 5 months admitted with newly onset fever and gastrointestinal complaints." | 2.66 | Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review. ( Coskun Benlidayi, I; Guzel, R; Kurtaran, B; Tirasci, E, 2020) |
| "Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever." | 1.56 | Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report. ( Daneshpazhooh, M; Isazade, A; Noormohammadpour, P; Soori, T, 2020) |
| " We also comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone." | 1.56 | ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency. ( Arlt, W; Baldeweg, SE; Pearce, SHS; Simpson, HL, 2020) |
| "Health-care providers worldwide in the coronavirus disease 2019 pandemic have been confronted with an unprecedented number of viral lung infections, with great variance in symptoms and severity." | 1.56 | Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019. ( Beyer, M; Fogarassy, P; Hellmich, B; Löffler, C; Mahrhold, J, 2020) |
| " For the treatment of COVID-19 pneumonia, systemic and in-depth investigation is needed to determine the timing and dosage of glucocorticoids needed to inhibit overwhelming inflammatory response and not the protective immune response to COVID-19 pneumonia." | 1.56 | Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience. ( Hu, Y; Hu, Z; Li, L; Peng, P; Wang, T; Wang, X; Zhang, Z, 2020) |
| "They also presented with pulmonary fibrosis findings, including traction bronchiectasis and marked lung volume reduction." | 1.56 | Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. ( Akiyama, Y; Fukunaga, K; Hasegawa, N; Ishii, M; Kabata, H; Kaneko, Y; Kondo, Y; Lee, H; Okamori, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 17 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daneshpazhooh, M | 1 |
| Soori, T | 1 |
| Isazade, A | 1 |
| Noormohammadpour, P | 1 |
| Arlt, W | 1 |
| Baldeweg, SE | 1 |
| Pearce, SHS | 1 |
| Simpson, HL | 1 |
| Grinspan, ZM | 1 |
| Mytinger, JR | 1 |
| Baumer, FM | 1 |
| Ciliberto, MA | 1 |
| Cohen, BH | 1 |
| Dlugos, DJ | 1 |
| Harini, C | 1 |
| Hussain, SA | 1 |
| Joshi, SM | 1 |
| Keator, CG | 1 |
| Knupp, KG | 1 |
| McGoldrick, PE | 1 |
| Nickels, KC | 1 |
| Park, JT | 1 |
| Pasupuleti, A | 1 |
| Patel, AD | 1 |
| Pomeroy, SL | 1 |
| Shahid, AM | 1 |
| Shellhaas, RA | 1 |
| Shrey, DW | 1 |
| Singh, RK | 1 |
| Wolf, SM | 1 |
| Yozawitz, EG | 1 |
| Yuskaitis, CJ | 1 |
| Waugh, JL | 1 |
| Pearl, PL | 1 |
| Coleman, H | 1 |
| Snell, LB | 1 |
| Simons, R | 1 |
| Douthwaite, ST | 1 |
| Lee, MJ | 1 |
| Asfuroglu Kalkan, E | 1 |
| Ates, I | 1 |
| Coskun Benlidayi, I | 1 |
| Kurtaran, B | 1 |
| Tirasci, E | 1 |
| Guzel, R | 1 |
| Löffler, C | 1 |
| Mahrhold, J | 1 |
| Fogarassy, P | 1 |
| Beyer, M | 1 |
| Hellmich, B | 1 |
| Dahl Mathiasen, V | 1 |
| Jensen-Fangel, S | 1 |
| Skov, K | 1 |
| Leth, S | 1 |
| Kuzeva, A | 1 |
| Dost, S | 1 |
| Lams, B | 1 |
| Agarwal, S | 1 |
| Furmedge, DS | 1 |
| Hu, Y | 1 |
| Wang, T | 1 |
| Hu, Z | 1 |
| Wang, X | 1 |
| Zhang, Z | 1 |
| Li, L | 1 |
| Peng, P | 1 |
| Mattar, SAM | 1 |
| Koh, SJQ | 1 |
| Rama Chandran, S | 1 |
| Cherng, BPZ | 1 |
| Okamori, S | 1 |
| Lee, H | 1 |
| Kondo, Y | 1 |
| Akiyama, Y | 1 |
| Kabata, H | 1 |
| Kaneko, Y | 1 |
| Ishii, M | 1 |
| Hasegawa, N | 1 |
| Fukunaga, K | 1 |
| Schramm, MA | 1 |
| Venhoff, N | 1 |
| Wagner, D | 1 |
| Thiel, J | 1 |
| Huzly, D | 1 |
| Craig-Mueller, N | 1 |
| Panning, M | 1 |
| Hengel, H | 1 |
| Kern, WV | 1 |
| Voll, RE | 1 |
| Nofal, A | 1 |
| Fawzy, MM | 1 |
| Sharaf El Deen, SM | 1 |
| El-Hawary, EE | 1 |
| Koumpa, FS | 1 |
| Forde, CT | 1 |
| Manjaly, JG | 1 |
| Tzukert, K | 1 |
| Abel, R | 1 |
| Mor Yosef Levi, I | 1 |
| Gork, I | 1 |
| Yosha Orpaz, L | 1 |
| Azmanov, H | 1 |
| Dranitzki Elhalel, M | 1 |
| Ahmadinejad, Z | 1 |
| Assari, R | 1 |
| Ayoobi Yazdi, N | 1 |
| Mazloomi, SH | 1 |
| Javanshayani, P | 1 |
| Khalili Afousi, H | 1 |
| Ziaee, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Thyroid Function Tests and the Status of Thyroid Autoantibodies in Hospitalized Covid-19 Patients and Their Relationship With White Blood Cells, Neutrophil / Lymphocyte Ratio, c Reactive Protein, Fibrinogen, Procalcitonin, Ferritin and D-dimer[NCT04659200] | 20 participants (Actual) | Observational | 2020-09-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Infections, Coronavirus
| Article | Year |
|---|---|
Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antirheumatic Agents; Betacoronavirus; Coronaviru | 2020 |
16 other studies available for prednisolone and Infections, Coronavirus
| Article | Year |
|---|---|
Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; C | 2020 |
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency.
Topics: Acute Disease; Adrenal Insufficiency; Adult; Betacoronavirus; Child; Child, Preschool; Coronavirus I | 2020 |
Crisis Standard of Care: Management of Infantile Spasms during COVID-19.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Betacoronavirus; Coronavirus Infections; COVID-19; Del | 2020 |
Coronavirus disease 2019 and Pneumocystis jirovecii pneumonia: a diagnostic dilemma in HIV.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Asthma; Betacoronavirus; Clinical Laboratory Techniques; Cor | 2020 |
A case of subacute thyroiditis associated with Covid-19 infection.
Topics: Adult; Anti-Inflammatory Agents; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; C | 2020 |
Two Immunocompromised Patients With Diffuse Alveolar Hemorrhage as a Complication of Severe Coronavirus Disease 2019.
Topics: Aged; Aortitis; Autoimmune Diseases; Betacoronavirus; Carcinoma, Transitional Cell; Chemoradiotherap | 2020 |
Uneventful case of COVID-19 in a kidney transplant recipient.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Female; Glucocorticoids; Hospitalization; Humans; | 2020 |
Time-critical administration of corticosteroid rescue therapy for COVID-19 pneumonitis in a ward-based patient with chronic obstructive pulmonary disease.
Topics: Aged; Betacoronavirus; C-Reactive Protein; Clinical Deterioration; Coronavirus Infections; COVID-19; | 2020 |
Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Clinical Laboratory Techniques; Coinfec | 2020 |
Subacute thyroiditis associated with COVID-19.
Topics: Adult; Betacoronavirus; Coronavirus Infections; COVID-19; Diagnosis, Differential; Glucocorticoids; | 2020 |
Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports.
Topics: Antiviral Agents; Coronavirus Infections; COVID-19; Disease Progression; Dose-Response Relationship, | 2020 |
COVID-19 in a Severely Immunosuppressed Patient With Life-Threatening Eosinophilic Granulomatosis With Polyangiitis.
Topics: Adult; Antiviral Agents; Betacoronavirus; Churg-Strauss Syndrome; Coronavirus Infections; COVID-19; | 2020 |
Herpes zoster ophthalmicus in COVID-19 patients.
Topics: Acyclovir; Administration, Cutaneous; Administration, Oral; Adult; Antiviral Agents; Betacoronavirus | 2020 |
Sudden irreversible hearing loss post COVID-19.
Topics: Administration, Oral; Betacoronavirus; Coronavirus Infections; COVID-19; Glucocorticoids; Hearing Lo | 2020 |
The Challenge of Treating Kidney Transplant Recipients Infected with COVID-19: Report of the First Cases in Israel.
Topics: Anti-Infective Agents; Azithromycin; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus In | 2020 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Beta | 2020 |